Equillium logo

Equillium

EQ | NASDAQ
Chart Builder DCF Calculator
$1.15
-$0.14 (-10.85%)
At close: Nov 16, 2026, 4:00 PM ET
$1.15
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
-10.85%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
25
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #929/1021 (Top 91%)

Key Statistics

Market Data

Market Cap $128.71M
1D Range
1.14 1.28
52W Range
0.85 3.20

Valuation (TTM)

PE -6.39
PB 2.44
EV/EBITDA -4.08

Valuation (NTM)

Forward PE N/A
Forward PEG 0.14
Price Target $5.50
Loading financial charts...

Profile

Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorde...

Sector Healthcare
Industry Biotechnology
Employees 14
IPO Date Oct 12, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$5.50
Upside
+378.26%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.